ClinicalTrials.Veeva

Menu
M

Midwest Cardiovascular Research and Education Foundation | Elkhart, IN

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Empagliflozin
BI 690517
Aspirin
Plozasiran
Vicadrostat
Obicetrapib
Dabigatran
lisinopril
Prasugrel
losartan

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 17 total trials
Locations recently updated

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People ca...

Enrolling
Heart Failure
Drug: Placebo
Drug: empagliflozin
Locations recently updated

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left...

Enrolling
Heart Failure
Drug: empagliflozin
Drug: placebo

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Obicetrapib
Drug: Placebo
Locations recently updated

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat
Locations recently updated

This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF...

Enrolling
Heart Failure With Preserved Ejection Fraction
Obesity
Drug: Placebo
Drug: Maridebart cafraglutide

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). A...

Active, not recruiting
Hypertriglyceridemia
Drug: Placebo
Drug: Plozasiran Injection

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (...

Active, not recruiting
Severe Hypertriglyceridemia
Drug: Placebo
Drug: Plozasiran Injection

Trial sponsors

Boehringer Ingelheim logo
Amgen logo
Arrowhead Pharmaceuticals logo
Bayer logo
B
N
University of British Columbia logo
University of Florida logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems